| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $983.6M | $890.2M | $833.3M |
| YoY Revenue Growth % | +10.5% | +6.8% | — |
| Gross Profit | $421.4M | $380.0M | — |
| Gross Margin % | 42.8% | 42.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $230.7M | $227.0M | $259.8M |
| Operating Margin % | 23.5% | 25.5% | 31.2% |
| Net Income (GAAP) | $159.6M | $161.3M | $182.9M |
| EBITDA (Normalized) | $311.8M | $290.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $135.8M | $170.5M | $138.8M |
| Capital Expenditures (CapEx) | $101.3M | $79.6M | — |
| Free Cash Flow (FCF) | $34.5M | $91.0M | $138.8M |
| FCF Margin % | 3.5% | 10.2% | 16.7% |
| Return on Invested Capital (ROIC %) | 23.3% | 29.7% | — |
| Cash & Short-Term Equivalents | $100.9M | $134.9M | — |
| Total Debt (Short + Long Term) | $171.2M | $108.2M | — |
| Total Stockholders' Equity | $713.1M | $631.2M | — |